Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Cronos Group	Tilray	Aurora Cannabis	Sundial Growers	USANA Health Sciences
Symbol	NASDAQ:CRON	NASDAQ:TLRY	NYSE:ACB	NASDAQ:SNDL	NYSE:USNA
Price Information
Current Price	$8.88	$19.76	$8.91	$1.00	$99.89
52 Week Range	Hold	Hold	Hold	Sell	Buy
MarketRank™
Overall Score	0.8	1.0	1.3	1.0	2.0
Analysis Score	0.9	2.0	2.8	0.7	3.5
Community Score	2.3	2.3	2.3	3.0	2.2
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	1.7
Earnings & Valuation Score	0.6	0.6	1.3	1.3	2.5
Analyst Ratings
Consensus Recommendation	Hold	Hold	Hold	Sell	Buy
Consensus Price Target	$8.50	$18.31	$10.93	$0.73	$126.00
% Upside from Price Target	-4.28% downside	-7.35% downside	22.63% upside	-26.67% downside	26.14% upside
Trade Information
Market Cap	$3.20 billion	$3.39 billion	$1.76 billion	$1.66 billion	$2.06 billion
Beta	2.07	3.12	3.44	7.01	0.98
Average Volume	6,129,464	39,321,609	22,186,193	499,869,844	118,913
Sales & Book Value
Annual Revenue	$25.64 million	$166.98 million	$207.89 million	$75.86 million	$1.06 billion
Price / Sales	124.77	20.33	8.49	21.89	1.94
Cashflow	$0.60 per share	N/A	N/A	N/A	$7.23 per share
Price / Cash	14.76	N/A	N/A	N/A	13.82
Book Value	$5.01 per share	$2.78 per share	$13.73 per share	$1.56 per share	$16.25 per share
Price / Book	1.77	7.11	0.65	0.64	6.15
Profitability
Net Income	$1.17 billion	$-321,170,000.00	$-2,468,190,000.00	$-204,570,000.00	$100.53 million
EPS	$0.67	($1.69)	($2.86)	($3.17)	$4.41
Trailing P/E Ratio	37.00	N/A	N/A	N/A	18.50
Forward P/E Ratio	N/A	N/A	N/A	N/A	18.33
P/E Growth	N/A	N/A	N/A	N/A	0.96
Net Margins	266.31%	-242.60%	-1,238.94%	-415.89%	10.57%
Return on Equity (ROE)	-1.61%	-92.70%	-16.32%	-187.67%	32.91%
Return on Assets (ROA)	-1.41%	-20.70%	-13.12%	-72.67%	22.26%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	2.75%	0.17%	0.66%	N/A
Current Ratio	9.75%	2.28%	1.88%	0.85%	2.40%
Quick Ratio	9.36%	1.61%	1.07%	0.50%	1.91%
Ownership Information
Institutional Ownership Percentage	11.75%	12.62%	11.86%	3.32%	54.12%
Insider Ownership Percentage	7.93%	16.75%	N/A	N/A	45.40%
Miscellaneous
Employees	631	1,646	2,731	868	1,943
Shares Outstanding	360.26 million	171.76 million	197.98 million	1.66 billion	20.62 million
Next Earnings Date	5/14/2021 (Estimated)	5/10/2021 (Estimated)	5/13/2021 (Estimated)	5/21/2021 (Estimated)	4/27/2021 (Confirmed)
Optionable	Optionable	Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Do USANA Health Sciences's (NYSE:USNA) Earnings Warrant Your Attention? finance.yahoo.com - April 9 at 5:31 PM
	USANA Dives Into Partnership With USA Swimming finance.yahoo.com - April 7 at 12:32 PM
	Usana Health Sciences Stock Appears To Be Fairly Valued finance.yahoo.com - March 28 at 5:53 PM
	USANA Health Sciences (NYSE:USNA) versus Aphria (NASDAQ:APHA) Head-To-Head Review americanbankingnews.com - March 24 at 10:58 AM
	USNA vs. ZTS: Which Stock Should Value Investors Buy Now? finance.yahoo.com - March 17 at 1:38 PM
	Applying New 3Rs Gets Workers through Pandemic, Global Author/CEO Says finance.yahoo.com - March 17 at 1:38 PM
	At US$96.90, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List? finance.yahoo.com - March 10 at 12:59 PM
	USANA Health (USNA) Soars to 52-Week High, Time to Cash Out? finance.yahoo.com - March 5 at 2:14 PM
	USNA or ZTS: Which Is the Better Value Stock Right Now? finance.yahoo.com - March 1 at 2:35 PM
	USANA executive director recognized as a top young leader in Utah finance.yahoo.com - February 25 at 2:22 PM
	USANA Announces Formation of Board Sustainability Committee finance.yahoo.com - February 16 at 7:19 PM
	Moving Average Crossover Alert: USANA Health Sciences (USNA) nasdaq.com - February 16 at 9:15 AM
	USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - February 12 at 9:29 AM
	Does This Valuation Of USANA Health Sciences, Inc. (NYSE:USNA) Imply Investors Are Overpaying? finance.yahoo.com - February 11 at 1:43 PM
	USNA vs. CTLT: Which Stock Is the Better Value Option? finance.yahoo.com - February 11 at 1:43 PM
	Why AzurRx BioPharma, Usana Health Are Moving Today msn.com - February 10 at 2:25 PM
	Price Over Earnings Overview: Usana Health Sciences finance.yahoo.com - February 10 at 2:24 PM
	USANA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call Presentation seekingalpha.com - February 10 at 5:11 AM
	USANA Health Sciences Announces Gain In Q4 Earnings nasdaq.com - February 9 at 7:15 PM
	USANA Health Sciences Finishes Strong 2020 with 14.5% Fourth Quarter Net Sales Growth and 32.6% Diluted EPS Growth finance.yahoo.com - February 9 at 7:15 PM
	USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates finance.yahoo.com - February 9 at 7:15 PM
	Usana Health Sciences Earnings Preview finance.yahoo.com - February 8 at 1:52 PM
	USNA: Lowering target price to $87.00 finance.yahoo.com - February 5 at 12:09 AM
	Country Music Star Influences Global CEO finance.yahoo.com - February 2 at 8:54 AM
	Are Investors Overlooking Returns On Capital At USANA Health Sciences (NYSE:USNA)? finance.yahoo.com - January 15 at 3:10 PM

Date	Company	Brokerage	Action
3/1/2021	Cronos Group	Raymond James	Set Price Target
3/1/2021	Cronos Group	Canaccord Genuity	Boost Price Target
2/22/2021	Cronos Group	CIBC	Downgrade
2/4/2021	Cronos Group	Stifel Nicolaus	Reiterated Rating
11/16/2020	Cronos Group	Jefferies Financial Group	Lower Price Target
5/11/2020	Cronos Group	Pi Financial	Reiterated Rating
4/19/2020	Cronos Group	Piper Sandler	Downgrade
4/2/2020	Cronos Group	Bank of America	Downgrade
3/4/2020	Cronos Group	MKM Partners	Upgrade
2/25/2021	Tilray	Benchmark	Reiterated Rating
2/18/2021	Tilray	Roth Capital	Boost Price Target
2/18/2021	Tilray	Alliance Global Partners	Boost Price Target
2/18/2021	Tilray	BMO Capital Markets	Boost Price Target
2/16/2021	Tilray	Cantor Fitzgerald	Boost Price Target
8/11/2020	Tilray	Northland Securities	Reiterated Rating
8/10/2020	Tilray	Oppenheimer	Reiterated Rating
2/12/2021	Aurora Cannabis	Needham & Company LLC	Downgrade
2/12/2021	Aurora Cannabis	Desjardins	Downgrade
11/16/2020	Aurora Cannabis	Atb Cap Markets	Upgrade
9/23/2020	Aurora Cannabis	Cowen	Reiterated Rating
9/27/2019	Sundial Growers	Barclays	Initiated Coverage
5/12/2020	USANA Health Sciences	Tigress Financial	Reiterated Rating
7/24/2019	USANA Health Sciences	Pivotal Research	Reiterated Rating
7/3/2019	USANA Health Sciences	Sidoti	Downgrade

(Data available from 4/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources